Robert Stott is an Editorial Director at Healio. He specializes in medicine and healthcare, with a focus on various medical specialties including rheumatology, gastroenterology, and hematology/oncology, among others. His work has been recognized with multiple APEX and ASHPE awards, highlighting his contributions to the field of medical journalism.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Not enough data
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Robert Stott, Heather Biele
Video Player is loading. Play Video Play Mute Current Time Duration Loaded Stream Type
By: Heather Biele, Robert Stott
One AI-powered health care data company is leveraging its proprietary large language model-based platform to automate chart review to prescreen potential candidates for clinical trials and observational studies.
By: Jennifer R. Southall
Arcascope — a circadian health company — is leveraging its combination of AI, mathematical models and wearable devices to assess how a patient’s body changes throughout the day, and determine when cancer therapy will be most effective.“We’re harnessing how the body changes over the course of the day to do a better job of developing medicine,” Olivia Walch, PhD,
By: Robert Stott, Edward V. Loftus Jr.
In a Healio video exclusive, Edward V. Loftus Jr., MD, discusses how early successes of genetically modified pig liver transplantation may resolve critical global shortages of human donor livers, but not without “challenges along the way.”
By: Robert Stott
In a Healio video exclusive, Kristin Daly, MSN, ANP-BC, AOCNP, urged oncology nurses to prioritize retirement planning, warning they may be leaving compensation on the table by not utilizing employer-matched 401(k) and 403(b) benefits.
By: Erin L. Boyle, Edward V. Loftus Jr.
In a Healio video exclusive, Edward V. Loftus Jr., MD, discusses lingering questions on the potential risks that gender-affirming hormone therapy may have for transgender patients with inflammatory bowel disease.
